Researchers found that patients who took statins alongside apalutamide and standard hormone therapy had higher three-year ...
Bristol Myers Squibb today announced updated data and first disclosure of results in chronic, refractory autoimmune diseases from the Phase 1 Breakfree-1 study (NCT05869955) of its investigational, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback